Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Quell Therapeutics to Participate at Upcoming Healthcare Investor Conferences
-
Abcourt Confirms Gravimetric Gold Recovery from High-Grade Horse Zone on its Flordin Property
-
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2024 Financial Results
-
Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing Partnership
-
Habit Burger & Grill Launches Sixth Restaurant in Southern Pines, North Carolina
-
Stock Yards Bancorp to Participate in the Piper Sandler 2024 East Coast Financial Services Conference
-
Brink's Announces Third-Quarter Results
-
Ocular Therapeutix™ to Report Third Quarter 2024 Results on November 14, 2024
-
Altimmune to Participate at Two Upcoming Investor Conferences
-
Brink's Announces Third-Quarter Results
-
Genie Energy Announces Third Quarter 2024 Results
-
Arbutus Reports Third Quarter 2024 Financial Results and Provides Corporate Update
-
Zevra Therapeutics to Participate at the Guggenheim Securities Healthcare Innovation Conference on Wed, Nov. 13
-
DEMESNE RESOURCES ANNOUNCES DEFINITIVE OPTION AGREEMENT TO ACQUIRE IMA MINE TUNGSTEN PROJECT IN IDAHO, U.S.
-
MasterCraft Boat Holdings, Inc. Reports Fiscal 2025 First Quarter Results
-
Habit Burger & Grill Launches Sixth Restaurant in Southern Pines, North Carolina
-
Quell Therapeutics to Participate at Upcoming Healthcare Investor Conferences
-
Kornit Digital Reports Third Quarter 2024 Results
-
Orion Reports Q2’25 Results with Revenue of $19.4M, Reflecting 40% Growth in EV Charging and Significant Improvement in Maintenance Segment Gross Margin
-
Hepsiburada Announces the Second Bond Issuance of Hepsifinans
-
Royalty Pharma Reports Third Quarter 2024 Results
-
Foresight Ventures Partners with The Block to Foster World-Class Conversations at Emergence Conference in Prague
-
Vertex Announces Third Quarter 2024 Financial Results
-
Vishay Intertechnology Reports Third Quarter 2024 Results
-
Clearside Biomedical to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference
-
Avista Corp. Reports Financial Results for the Third Quarter of 2024
-
Helium Evolution Provides Well Results and Announces Partner to Drill Additional Joint Well
-
Olema Oncology to Participate in Upcoming Investor Conferences
-
Astec Reports Third Quarter 2024 Results
-
BioCryst to Present at Upcoming Investor Conferences
-
The 2024 Zhengzhou Marathon Successfully Concludes, with Surname Culture and Shaolin Kung Fu Shining Together
-
Invivyd to Host Third Quarter 2024 Financial Results and Corporate Update Conference Call on November 14, 2024
-
BrainBox AI announced as one of Canada’s Companies-to-Watch in the 2024 Technology Fast 50 program
-
Amicus Therapeutics Announces Third Quarter 2024 Financial Results and Corporate Updates
-
LIV Design Studio Announces the Return of the Student Design Challenge for a Third Year at IDS Toronto 2025
-
BioCardia to Host Q3 2024 Corporate Update and Financial Results Conference Call on November 13, 2024
-
Kamada to Announce Third Quarter and Nine-Months Ended September 30, 2024 Financial Results and Host Conference Call on November 13, 2024
-
Sprott Announces Third Quarter 2024 Results
-
BitSmiley, a Bitcoin-native Stablecoin Protocol, Will Be Initially Listed on CoinW Exchange
-
Vishay Intertechnology to Acquire Birkelbach, Manufacturer of Metalized Technical Films
-
Secura Bio Announces Poster Presentation Highlighting New COPIKTRA® (duvelisib) Data for the Treatment of Patients With Peripheral T-Cell Lymphoma and Other Advanced Hematologic Malignancies at the 2
-
Seres Therapeutics to Announce Third Quarter 2024 Financial Results and Business Updates on November 13, 2024
-
American Shared Hospital Services Announces Third Quarter 2024 Earnings Conference Call
-
Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences
-
Krystal Biotech to Present at Guggenheim Securities Healthcare Innovation Conference
-
Cellebrite Announces Third-Quarter 2024 Results
-
BioRestorative Therapies to Present New Clinical Data at the ORS PSRS 7th International Spine Research Symposium
-
YHN Acquisition I Limited Announces the Separate Trading of its Ordinary Shares and Rights, Commencing November 8, 2024
-
WW International, Inc. Announces Third Quarter 2024 Results
-
Macerich Reports Third Quarter 2024 Results

